Zeneca Pharma

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's primary focus areas include Oncology, Cardiovascular, Renal & Metabolism (CVRM), and Respiratory & Immunology. AstraZeneca is well-known for its extensive portfolio of blockbuster drugs such as Tagrisso, Imfinzi, and Farxiga, as well as its role in developing the Vaxzevria COVID-19 vaccine. Following the acquisition of Alexion Pharmaceuticals, the company has also established a significant presence in Rare Diseases. AstraZeneca operates in over 100 countries and maintains a robust pipeline across multiple therapeutic modalities including small molecules and biologics.